Art

J-GLOBAL ID：202002287322458227   Reference number：20A0273699

Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients

STK11におけるゲノム変化は子宮頸癌患者の臨床転帰を予測できる【JST・京大機械翻訳】

Author (32)： Hirose Sou (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Hirose Sou (Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan) ,  Murakami Naoya (Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Takahashi Kazuaki (Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan) ,  Kuno Ikumi (Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan) ,  Takayanagi Daisuke (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Asami Yuka (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Asami Yuka (Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan) ,  Matsuda Maiko (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Shimada Yoko (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Yamano Shotaro (Japan Bioassay Research Center, Japan Organization of Occupational Health and Safety, Kanagawa, Japan) ,  Sunami Kuniko (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Yoshida Kazushi (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Yoshida Kazushi (Department of Respiratory Medicine, The Jikei University School of Medicine, Tokyo, Japan) ,  Honda Takayuki (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Honda Takayuki (Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan) ,  Nakahara Tomomi (Division of Carcinogenesis and Cancer Prevention, National Cancer Center Research Institute, Tokyo, Japan) ,  Watanabe Tomoko (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Komatsu Masaaki (Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Komatsu Masaaki (Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan) ,  Hamamoto Ryuji (Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Hamamoto Ryuji (Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan) ,  Kato Mayumi Kobayashi (Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan) ,  Matsumoto Koji (Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan) ,  Okuma Kae (Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Kuroda Takafumi (Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan) ,  Okamoto Aikou (Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan) ,  Itami Jun (Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Kohno Takashi (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Kato Tomoyasu (Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan) ,  Shiraishi Kouya (Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan) ,  Yoshida Hiroshi (Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan)
Material： Gynecologic Oncology  (Gynecol Oncol)
Volume： 156  Issue： 1  Page： 203-210  Publication year： 2020 
JST Material Number： E0561C  ISSN： 0090-8258  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Cervical cancer is the fourth ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0273699&from=J-GLOBAL&jstjournalNo=E0561C") }}

Thesaurus term： Adenocarcinoma ,  molecular target therapy ,  population (statistics) ,  survival ratio ,  copy number ,  wild type ,  Death ,  targeting ,  Mutation ,  *genome ,  Prognosis ,  woman ,  *cervix tumor ,  squamous cell carcinoma ,  TP53

Author keywords (3)： Cervical cancer ,  STK11 genomic alterations ,  Clinical outcomes

JST classification (1)： Tumors(=neoplasms)of female genitalia and fetus  (GS04000K)

Terms in the title (6)： STK11 ,  ゲノム ,  子宮頸 ,  癌患者 ,  臨床転帰 ,  予測